Plasma aldosterone concentration / plasma renin activity ratio in patients with essential hypertension before treatment

Back

ESC Professional Premium Access

Plasma aldosterone concentration / plasma renin activity ratio in patients with essential hypertension before treatment

Session: Biomarkers and genetics in hypertension

Topic: Renin-Angiotensin System

Speaker: Doctor M. Nakayama (Amakusa, JP)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Masafumi Nakayama

Nakayama Cardiovascular Clinic, Amakusa (Japan)

0 follower

6 more presentations in this session

Cardiovascular and metabolic effects of MANP. a novel GC-A activator, in human hypertension with metabolic syndrome

Speaker: Associate Professor V. Cannone (Parma, IT)

Contribution of TNF-R1 to reduced exercise capacity in hypertensive heart disease. Mediating role of left atrial mechanical function reserve

Speaker: Doctor J. Zachwyc (Wroclaw, PL)

New insights on the mechanisms of myocardial injury in hypertensive patients with COVID-19

Speaker: Doctor R. Moll Bernardes (Rio de Janeiro, BR)

Profile of miRNAs expression on serum of hypertensive patients with chronic kidney disease

Speaker: Associate Professor W. Nadruz (Campinas, BR)

G894T of nos3 gene polymorphism and resistant arterial hypertension in Uzbek population.

Speaker: Associate Professor G. Abdullaeva (Tashkent, UZ)

Access the full session

Biomarkers and genetics in hypertension

Speakers: Doctor M. Nakayama, Associate Professor V. Cannone, Doctor J. Zachwyc, Doctor R. Moll Bernardes, Associate Professor W. Nadruz...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources